Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.39
-0.03 (-0.12%)
Official Closing Price
Updated: 6:30 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Today 9:15 EDT
The answer to that question will either make you wince or smile.
Via
The Motley Fool
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
April 17, 2024
Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $100 Right Now
April 17, 2024
A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
Via
The Motley Fool
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
A Closer Look at Pfizer's Options Market Dynamics
April 15, 2024
Via
Benzinga
Is Pfizer Stock a Buy?
April 15, 2024
The pharmaceutical giant is laying the groundwork for its next heyday.
Via
The Motley Fool
Where Will Pfizer Stock Be in 10 Years?
April 10, 2024
Is this top healthcare stock a good buy for the long run?
Via
The Motley Fool
Decoding Pfizer's Options Activity: What's the Big Picture?
April 09, 2024
Via
Benzinga
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Via
The Motley Fool
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
April 15, 2024
The average yield from these stocks is more than five times the market average.
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
April 13, 2024
These three stocks are bargains with great dividends.
Via
The Motley Fool
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever
April 12, 2024
These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.
Via
The Motley Fool
Is Pfizer Stock the Biggest Bargain in the S&P 500?
April 12, 2024
When something seems too good to be true it might not be.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
April 11, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Current Analysis: Pfizer (PFE)
April 10, 2024
Pfizer (PFE) is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer’s share price fell 36.6% from $41.50 to $26.31 as of Wednesday’s...
Via
Talk Markets
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
April 10, 2024
The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the...
Via
Benzinga
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Via
InvestorPlace
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
April 10, 2024
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:
Via
Benzinga
PM Fumio Kishida Urges US Tech Giants To Invest In Japan: 'I'm Strongly Promoting Policies Toward The Next Economic Stage'
April 10, 2024
During a roundtable in Washington, Kishida highlighted the importance of U.S. investments in Japan, particularly in emerging technologies like semiconductors, AI, and quantum computing.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
April 09, 2024
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.
Via
InvestorPlace
Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients
April 09, 2024
Discover pivotal Phase 3 trial results for Pfizer's Abrysvo vaccine in adults 18-59 at risk of severe RSV disease. Achieved immunogenicity and safety milestones pave the way for potential regulatory...
Via
Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever
April 09, 2024
A rate cut would likely be a boon for these two ultra-high yield dividend stocks.
Via
The Motley Fool
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 09, 2024
These companies are close to launching new products that could supercharge revenue.
Via
The Motley Fool
3 Dirt-Cheap Stocks That Could Make You Filthy Rich
April 09, 2024
Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?
April 09, 2024
The current status of this stock might seem bleak. But like a chess grandmaster, Griffin is looking several moves ahead.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
Why Is Ocugen (OCGN) Stock Up 7% Today?
April 08, 2024
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.
Via
InvestorPlace
Exposures
COVID-19
Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'
April 08, 2024
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.